Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Liver transplantation is an important option for patients of neuroendocrine tumors (NET) with metastases limited to the liver. Peptide receptor radionuclide therapy (PRRNT) is effective in the management of metastatic NET.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Kulkarni H, Kaemmerer D, Hoersch D, Hommann M, Baum R,
Keywords: liver transplantation, peptide receptor radionuclide therapy,
Introduction: Hepatic metastases significantly affect the overall prognosis and quality of life in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET). Radiofrequency ablation (RFA) is one of the important local ablative strategies for hepatic metastases. Peptide receptor radionuclide therapy (PRRNT) is a well-established therapeutic modality for metastatic NET.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Kulkarni H, Kaemmerer D, Petrovich A, Hoersch D, Hommann M,
Keywords: Peptide receptor radionuclide therapy, radiofrequency ablation,
Introduction: Patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET) present frequently with hepatic metastases. Radiofrequency ablation (RFA) is an important local ablative treatment for hepatic metastases.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Kulkarni H, Kaemmerer D, Petrovich A, Hoersch D, Baum R,
Keywords: Somatostatin Receptor PET/CT, radiofrequency ablation, hepatic metastases,
Introduction: Everolimus, an oral inhibitor of mTOR, demonstrated promising antitumor activity in patients with NET as a single agent and in combination with octreotide LAR in two phase 2 studies.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Pavel M, Peeters M, Höersch D, Van Cutsem E, Öberg K,
Keywords: mTOR, everolimus, octreotide LAR, neuroendocrine tumor,
Introduction: Ga-68 Somatostatin-Receptor PET/CT (R-PET/CT) has been reported to be superior to In-111 octreoscan in the detection of unknown primary of neuroendocrine tumors (CUP-NET) (EJNMMI 2010 Jan;37(1):67-77)
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Prasad V, Hommann M, Settmacher U, Kaemmerer D, Hoersch D,
Keywords: CUP NET, Ga-68 SMS-R PET/CT,